Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy

Several retrospective and a few prospective studies have shown that metastasis-directed therapy (MDT) could delay clinical progression and postpone the initiation of systemic treatment in oligorecurrent prostate cancer (PCa) patients. However, these endpoints are strongly influenced by variables suc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Devos, Gaëtan, Berghen, Charlien, Van Eecke, Henri, Stichele, Arthur Vander, Van Poppel, Hendrik, Goffin, Karolien, Mai, Cindy, De Wever, Liesbeth, Albersen, Maarten, Everaerts, Wouter, De Meerleer, Gert, Joniau, Steven
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464259/
https://ncbi.nlm.nih.gov/pubmed/32823690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082271
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars